Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients
Fady Geara(The University of Texas MD Anderson Cancer Center), William A. Brock(The University of Texas MD Anderson Cancer Center), K. Kian Ang(Radiation Oncology Associates), Jennifer L. Wike(The University of Texas MD Anderson Cancer Center), Lester J. Peters(Fermi National Accelerator Laboratory)
International Journal of Radiation Oncology*Biology*Physics
December 1, 1993
Cited by 184
Related Papers
Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|1990|1.4k
Changes in early and late radiation responses with altered dose fractionation: Implications for dose-survival relationships
|International Journal of Radiation Oncology*Biology*Physics|1982|842
Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02
|Journal of Clinical Oncology|2010|806
Prognostic Significance of p16 <sup>INK4A</sup> and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial
|Journal of Clinical Oncology|2010|741
Prognostic Significance of [<sup>18</sup>F]-Misonidazole Positron Emission Tomography–Detected Tumor Hypoxia in Patients With Advanced Head and Neck Cancer Randomly Assigned to Chemoradiation With or Without Tirapazamine: A Substudy of Trans-Tasman Radiation Oncology Group Study 98.02
|Journal of Clinical Oncology|2006|543